The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-Ethylbutyl)-N-(3-(4-fluorophenoxy)-5-(4-methoxyphenoxy)phenyl)-4-hydroxypiperidine-1-carboxamide ID: ALA4459775
Chembl Id: CHEMBL4459775
PubChem CID: 155317227
Max Phase: Preclinical
Molecular Formula: C31H37FN2O5
Molecular Weight: 536.64
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCC(CC)CC1(O)CCN(C(=O)Nc2cc(Oc3ccc(F)cc3)cc(Oc3ccc(OC)cc3)c2)CC1
Standard InChI: InChI=1S/C31H37FN2O5/c1-4-22(5-2)21-31(36)14-16-34(17-15-31)30(35)33-24-18-28(38-26-8-6-23(32)7-9-26)20-29(19-24)39-27-12-10-25(37-3)11-13-27/h6-13,18-20,22,36H,4-5,14-17,21H2,1-3H3,(H,33,35)
Standard InChI Key: AGOAUMQIEHUSAF-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 536.64Molecular Weight (Monoisotopic): 536.2687AlogP: 7.60#Rotatable Bonds: 10Polar Surface Area: 80.26Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.63CX Basic pKa: ┄CX LogP: 6.05CX LogD: 6.05Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -0.76
References 1. Luo Z, Liu H, Klein RS, Tu Z.. (2019) Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor., 27 (16): [PMID:31279524 ] [10.1016/j.bmc.2019.06.047 ]